中国科学院机构知识库网格
Chinese Academy of Sciences Institutional Repositories Grid
首页
机构
成果
学者
登录
注册
登陆
×
验证码:
换一张
忘记密码?
记住我
×
校外用户登录
CAS IR Grid
机构
上海药物研究所 [122]
采集方式
OAI收割 [122]
内容类型
期刊论文 [122]
发表日期
2024 [4]
2023 [6]
2022 [10]
2021 [15]
2020 [10]
2019 [5]
更多
学科主题
筛选
浏览/检索结果:
共122条,第1-10条
帮助
限定条件
专题:上海药物研究所
第一署名单位
第一作者单位
通讯作者单位
条数/页:
5
10
15
20
25
30
35
40
45
50
55
60
65
70
75
80
85
90
95
100
排序方式:
请选择
提交时间升序
提交时间降序
发表日期升序
发表日期降序
题名升序
题名降序
作者升序
作者降序
Discovery of GPX4 inhibitors through FP-based high-throughput screening
期刊论文
OAI收割
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2024, 卷号: 265, 页码: 14
作者:
Cao, Yu
;
Wu, Bin
;
Xu, Ying
;
Wang, Mingchen
;
Wu, Xinyu
  |  
收藏
  |  
浏览/下载:22/0
  |  
提交时间:2024/02/27
GPX4 inhibitor
HTS assay
Ferroptosis
Fluorescence polarization
Safety, pharmacokinetics, and food effect of sudapyridine (WX-081), a novel anti-tuberculosis candidate in healthy Chinese subjects
期刊论文
OAI收割
CTS-CLINICAL AND TRANSLATIONAL SCIENCE, 2024, 卷号: 17, 期号: 2, 页码: 10
作者:
Yu, Chengyin
;
Qian, Hongjie
;
Wu, Qingqing
;
Zou, Yang
;
Ding, Qicheng
  |  
收藏
  |  
浏览/下载:15/0
  |  
提交时间:2024/03/06
Benzothiozinone derivatives with anti-tubercular Activity-Further side chain investigation
期刊论文
OAI收割
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2024, 卷号: 264, 页码: 11
作者:
Wu, Xiaomei
;
Wang, Wenxin
;
Stelitano, Giovanni
;
Riabova, Olga
;
Wang, Bin
  |  
收藏
  |  
浏览/下载:8/0
  |  
提交时间:2024/01/26
Anti -tubercular activity
DprE1 inhibitor
Benzothiazinone derivatives
Structure activity relationship
Red blood cell membrane biomimetic nanoprobes for ratiometric imaging of reactive oxygen species level in atherosclerosis
期刊论文
OAI收割
CHEMICAL ENGINEERING JOURNAL, 2024, 卷号: 479, 页码: 14
作者:
Liu, Bo
;
Han, Gui-Mei
;
Wang, Dong-Xia
;
Liu, Ding -Bin
;
Liu, An -An
  |  
收藏
  |  
浏览/下载:13/0
  |  
提交时间:2024/03/25
Atherosclerosis
Reactive oxygen species
Biomimetic nanoprobes
In situ
Ratiometric imaging
Single-cell RNA sequencing reveals a hierarchical transcriptional regulatory network of terpenoid biosynthesis in cotton secretory glandular cells
期刊论文
OAI收割
MOLECULAR PLANT, 2023, 卷号: 16, 期号: 12, 页码: 1990-2003
作者:
Lin, Jia-Ling
;
Chen, Longxian
;
Wu, Wen-Kai
;
Guo, Xiao-Xiang
;
Yu, Cheng-Hui
  |  
收藏
  |  
浏览/下载:10/0
  |  
提交时间:2024/01/26
Controlling ESIPT-based AIE effects for designing optical materials with single-component white-light emission
期刊论文
OAI收割
CHEMICAL ENGINEERING JOURNAL, 2023, 卷号: 476, 页码: 11
作者:
Huang, Shuai
;
Feng, Bin
;
Cheng, Xiang
;
Huang, Xueyan
;
Ding, Jipeng
  |  
收藏
  |  
浏览/下载:29/0
  |  
提交时间:2024/01/16
Tunable aggregation-induced emission property
White-light emission
Dark state
Artificial intelligence
Intramolecular hydrogen bonding
Original Research Response to programmed cell death protein 1 antibody in patients with Epstein-Barr virus-associated intrahepatic cholangiocarcinoma
期刊论文
OAI收割
EUROPEAN JOURNAL OF CANCER, 2023, 卷号: 194, 页码: 9
作者:
He, Wen-Zhuo
;
Huang, Yu-Hua
;
Hu, Wan-Ming
;
Wang, Fang
;
Xu, Yu-Xia
  |  
收藏
  |  
浏览/下载:10/0
  |  
提交时间:2023/12/11
Epstein-Barr virus
Intrahepatic cholangiocarcinoma
Programmed cell death protein 1
Immunotherapy
Liang-Ge-San inhibits dengue virus serotype 2 infection by reducing caveolin1-induced cytoplasmic heat shock protein 70 translocation into the plasma membrane
期刊论文
OAI收割
PHYTOMEDICINE, 2023, 卷号: 119, 页码: 14
作者:
Chen, Xi
;
Yang, Jia-bin
;
Cao, Hui-hui
;
Fang, Xiao-chuan
;
Liu, Shan-hong
  |  
收藏
  |  
浏览/下载:13/0
  |  
提交时间:2023/10/17
Liang-Ge-San
Dengue virus serotype 2
Heat shock protein 70
Caveolin1
Envelope protein
Antiandrogen treatment induces stromal cell reprogramming to promote castration resistance in cancer
期刊论文
OAI收割
CANCER CELL, 2023, 卷号: 41, 期号: 7, 页码: 1345-+
作者:
Wang, Hanling
;
Li, Ni
;
Liu, Qiuli
;
Guo, Jiacheng
;
Pan, Qiang
  |  
收藏
  |  
浏览/下载:18/0
  |  
提交时间:2023/10/17
Thioparib inhibits homologous recombination repair, activates the type I IFN response, and overcomes olaparib resistance
期刊论文
OAI收割
EMBO MOLECULAR MEDICINE, 2023, 页码: 24
作者:
Wang, Li-Min
;
Wang, Pingyuan
;
Chen, Xiao-Min
;
Yang, Hui
;
Song, Shan-Shan
  |  
收藏
  |  
浏览/下载:21/0
  |  
提交时间:2023/04/10
homologous recombination repair
olaparib-resistant
PARP inhibitor
PARP7
type I interferons